Pharmacokinetic Research Progress of Anti-tumor Drugs Targeting for Pulmonary Administration

被引:3
|
作者
Zhao, Mengfan [1 ]
Jing, Ziwei [1 ]
Zhou, Lin [1 ]
Zhao, Hongyu [2 ]
Du, Qiuzheng [1 ]
Sun, Zhi [1 ]
机构
[1] Zhengzhou Univ, Dept Pharm, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
基金
中国国家自然科学基金;
关键词
Lung cancer; inhalation preparation; drug carrier; pharmacokinetics; anti-tumor drugs; pulmonary administration; CELL LUNG-CANCER; MICELLIZING SOLID DISPERSION; DELIVERY-SYSTEMS; DRY POWDER; INHALATION TREATMENT; CYCLOSPORINE-A; PHASE-II; NANOPARTICLES; LIPOSOMES; FORMULATION;
D O I
10.2174/1389200221999201111193910
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Cancer is a major problem that threatens human survival and has a high mortality rate. The traditional chemotherapy methods are mainly intravenous injection and oral administration, but have obvious toxic and side effects. Anti-tumor drugs for pulmonary administration can enhance drug targeting, increase local drug concentration, and reduce the damage to systemic organs, especially for the treatment of lung cancer. Methods: The articles on the pharmacokinetics of anti-tumor drugs targeting pulmonary administration were retrieved from the Pub Med database. This article mainly took lung cancer as an example and summarized the pharmacokinetic characteristics of anti-tumor drugs targeting for pulmonary administration contained in nanoparticles, dendrimers, liposomes and micelles. Results: The review shows that the pharmacokinetics process of pulmonary administration is associated with a drug carrier by increasing the deposition and release of drugs in the lung, and retarding the lung clearance rate. Among them, the surface of dendrimers could be readily modified, and polymer micelles have favorable loading efficiency. In the case of inhalation administration, liposomes exhibit more excellent lung retention properties compared to other non-lipid carriers. Therefore, the appropriate drug carrier is instrumental to increase the curative effect of anti-tumor drugs and reduce the toxic effect on surrounding healthy tissues or organs. Conclusion: In the process of pulmonary administration, the carrier-embedded antitumor drugs have the characteristics of targeted and sustained release compared with non-packaging drugs, which provides a theoretical basis for the clinical rational formulation of chemotherapy regimens. llowever, there is currently a lack of comparative research between drug packaging materials, and more importantly, the development of safe and effective anti-tumor drugs targeting for pulmonary administration requires more data.
引用
收藏
页码:1117 / 1126
页数:10
相关论文
共 50 条
  • [31] The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy
    Lu, Chenglin
    Liu, Ying
    Ali, Nasra Mohamoud
    Zhang, Bin
    Cui, Xiaonan
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [32] DNA MODIFICATION BY ANTI-TUMOR DRUGS
    HASELTINE, WA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1980, 179 (MAR): : 24 - MEDI
  • [33] Midkine as anti-tumor drugs for osteosarcoma
    Maehara, Hiroki
    Kaname, Tadashi
    Yanagi, Kumiko
    Tome, Yasunori
    Tanaka, Kazuhiro
    Hanzawa, Hiroaki
    Owan, Ichiro
    Naritomi, Kenji
    Kanaya, Fuminori
    CANCER RESEARCH, 2009, 69
  • [34] ANTI-MICROBIAL ACTIVITY OF ANTI-TUMOR DRUGS
    TILLOTSON, JR
    HENZE, ES
    CLINICAL RESEARCH, 1978, 26 (03): : A594 - A594
  • [35] Research Progress of Constructing Selenium Nanoparticles by Polysaccharide Carriers and Their Application in Anti-tumor
    Liu X.
    Wei L.
    Jia J.
    Zhou J.
    Cheng S.
    Cai J.
    Science and Technology of Food Industry, 2022, 43 (21) : 454 - 460
  • [36] Research progress on synergistic anti-tumor mechanisms of compounds inTraditional Chinese Medicine
    Jing Zhou
    Tianyao Zhou
    Meijuan Chen
    Miao Jiang
    Xiaoxia Wang
    Qin Liu
    Zhen Zhan
    Xu Zhang
    JournalofTraditionalChineseMedicine, 2014, 34 (01) : 100 - 105
  • [37] Research progress on synergistic anti-tumor mechanisms of compounds in Traditional Chinese Medicine
    Zhou, Jing
    Zhou, Tianyao
    Chen, Meijuan
    Jiang, Miao
    Wang, Xiaoxia
    Liu, Qin
    Zhan, Zhen
    Zhang, Xu
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2014, 34 (01) : 100 - 105
  • [38] Recent progress of research on anti-tumor agents using benzimidazole as the structure unit
    Wu, Kaiyue
    Peng, Xiaoyu
    Chen, Miaojia
    Li, Yang
    Tang, Guotao
    Peng, Junmei
    Peng, Yuanyuan
    Cao, Xuan
    CHEMICAL BIOLOGY & DRUG DESIGN, 2022, 99 (05) : 736 - 757
  • [39] RESEARCH PROGRESS ON PREPARATION AND ANTI-TUMOR APPLICATION OF COPPER SULFIDE NANOCOMPOSITES: A REVIEW
    Feng, Yuanjiao
    Miao, Home
    Zeng, Xue
    Zhong, Wenwu
    ACTA POLONIAE PHARMACEUTICA, 2023, 80 (01): : 3 - 12
  • [40] Increasing Targeting and Efficacy of Anti-Tumor Antibody
    McKetney, Justin
    Kerr, Rebecca
    Collins, Edward J.
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 629A - 629A